<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03018301</url>
  </required_header>
  <id_info>
    <org_study_id>IRB0000871238</org_study_id>
    <nct_id>NCT03018301</nct_id>
  </id_info>
  <brief_title>Intravenous Ketamine and Postoperative Pain Following Cesarean Section.</brief_title>
  <official_title>Effect of Single Intravenous Ketamine Dose on Postoperative Pain Following Cesarean Section Under Spinal Anesthesia: A Randomized Control Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the analgesic effect of low-dose intravenous
      ketamine in pregnant mothers undergoing cesarean section under Bupivacaine spinal anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  No premedication will be given, and patients will be monitored by electrocardiogram,
           non-invasive arterial blood pressure, and pulse oximetry when they entered the operating
           room.

        -  18 gauge IV cannula will be inserted and all patients will be preloaded with 10 ml/kg of
           lactate ringer over 20 min period.

        -  All participants will have spinal anesthesia using bupivacaine. The dose of the drug, as
           well as the method of injection will be identical for all individuals; 10 mg (2 cc
           0.5%), in the L4-L5 space using needle 25 G, midline, with the patient in a sitting
           position.

        -  After administering bupivacaine, and prior to surgery the height of the sensory block
           will be assessed bilaterally (complete loss of sensation to ice) in a ascending fashion
           starting from T12 dermatome.

        -  Once adequate anesthesia to at least T6 dermatome will be achieved, the operation will
           be allowed to begin. When systolic blood pressure decrease to ＜ 90 mmHg, or 30% of the
           pre-anesthetic blood pressure, it will be corrected by administering 5 mg ephedrine.

        -  Patients will be asked to report any intraoperative pain using visual pain score(VPS)of
           0(no pain) 10(worst pain).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>• Number of Subjects Requiring Supplemental Analgesia</measure>
    <time_frame>24 hours postoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cumulative morphine/paracetamol</measure>
    <time_frame>24 hours postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of subjects reporting nausea, vomiting</measure>
    <time_frame>24 hours postoperative</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Ketamine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>will receive 0.25 mg/kg intravenous ketamine diluted with normal saline to 20 ml delivered over 10 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>will receive intravenous 20 ml of normal saline, delivered over 10 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>will receive 0.25 mg/kg intravenous ketamine diluted with normal saline to 20 ml delivered over 10 minutes.</description>
    <arm_group_label>Ketamine group</arm_group_label>
    <other_name>Ketalar</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>will receive intravenous 20 ml of normal saline, delivered over 10 minutes.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Eligible women ASA class 1 and 2, are at term (≥37 week gestation), Scheduled for
             elective cesarean section whose anesthetic plan is for spinal anesthesia with
             Bupivacaine and intravenous pethidine and paracetamol for post operative analgesia.

        Exclusion Criteria:

          -  • Body mass index ≥40 kg/m2,

               -  Known allergy to any of the study medications,

               -  Contraindication to the spinal anesthesia,

               -  History of substance abuse,

               -  History of hallucinations,

               -  Chronic opioid therapy,

               -  Chronic pain.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Israa M Sayed</last_name>
    <role>Study Chair</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Abdelrady S Ibrahim, MD</last_name>
    <phone>00201026249924</phone>
    <email>aradys2004@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hamdy A Yousef, MD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assiut university faculty of medicine</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abdelrady S Ibrahim, MD</last_name>
      <phone>00201026249924</phone>
      <email>aradys2004@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>El-Tahan MR, Warda OM, Yasseen AM, Attallah MM, Matter MK. A randomized study of the effects of preoperative ketorolac on general anaesthesia for caesarean section. Int J Obstet Anesth. 2007 Jul;16(3):214-20. Epub 2007 Apr 24.</citation>
    <PMID>17459695</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2017</study_first_submitted>
  <study_first_submitted_qc>January 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2017</study_first_posted>
  <last_update_submitted>January 10, 2017</last_update_submitted>
  <last_update_submitted_qc>January 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Abdelrady S Ibrahim, MD</investigator_full_name>
    <investigator_title>Assistant professor of anesthesia and ICU</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

